Literature DB >> 7836323

Preliminary structure determination of the capsular polysaccharide of Vibrio cholerae O139 Bengal Al1837.

L M Preston1, Q Xu, J A Johnson, A Joseph, D R Maneval, K Husain, G P Reddy, C A Bush, J G Morris.   

Abstract

Vibrio cholerae O139 Bengal has recently been identified as a cause of epidemic cholera in Asia. In contrast to V. cholerae O1, V. cholerae O139 Bengal has a polysaccharide capsule. As determined by high-performance anion-exchange chromatography and 1H nuclear magnetic resonance analysis, the capsular polysaccharide of V. cholerae O139 Bengal strain Al1837 has six residues in the repeating subunit; this includes one residue each of N-acetylglucosamine, N-acetylquinovosamine (QuiNAc), galacturonic acid (GalA), and galactose and two residues of 3,6-dideoxyxylohexose (Xylhex). The proposed structure is [formula: see text]

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7836323      PMCID： PMC176667          DOI： 10.1128/jb.177.3.835-838.1995

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  16 in total

1.  Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences.

Authors:  J A Johnson; C A Salles; P Panigrahi; M J Albert; A C Wright; R J Johnson; J G Morris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

2.  Vibrio cholerae O139 specific gene sequences.

Authors:  M K Waldor; J J Mekalanos
Journal:  Lancet       Date:  1994-05-28       Impact factor: 79.321

3.  Vibrio cholerae O139 in Karachi, Pakistan.

Authors:  S P Fisher-Hoch; A Khan; M A Khan; E D Mintz
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

4.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.

Authors:  T Ramamurthy; S Garg; R Sharma; S K Bhattacharya; G B Nair; T Shimada; T Takeda; T Karasawa; H Kurazano; A Pal
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

5.  O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent.

Authors:  K Hisatsune; S Kondo; Y Isshiki; T Iguchi; Y Kawamata; T Shimada
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

6.  Spread of Vibrio cholerae O139 Bengal in India.

Authors:  G B Nair; T Ramamurthy; S K Bhattacharya; A K Mukhopadhyay; S Garg; M K Bhattacharya; T Takeda; T Shimada; Y Takeda; B C Deb
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

7.  Molecular analysis of the 3,6-dideoxyhexose pathway genes of Yersinia pseudotuberculosis serogroup IIA.

Authors:  A C Kessler; A Haase; P R Reeves
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

8.  Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources.

Authors:  U Hayat; G P Reddy; C A Bush; J A Johnson; A C Wright; J G Morris
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

9.  Capsular polysaccharide structure of a clinical isolate of Vibrio vulnificus strain BO62316 determined by heteronuclear NMR spectroscopy and high-performance anion-exchange chromatography.

Authors:  G P Reddy; U Hayat; C A Bush; J G Morris
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

10.  The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.

Authors:  L E Comstock; D Maneval; P Panigrahi; A Joseph; M M Levine; J B Kaper; J G Morris; J A Johnson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441
View more
  8 in total

1.  Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation.

Authors:  F H Yildiz; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin.

Authors:  Z Kossaczka; S C Szu
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

3.  Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.

Authors:  A Boutonnier; S Villeneuve; F Nato; B Dassy; J M Fournier
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Novel Vibrio cholerae O139 genes involved in lipopolysaccharide biosynthesis.

Authors:  U H Stroeher; G Parasivam; B K Dredge; P A Manning
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

5.  Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.

Authors:  Z Kossaczka; J Shiloach; V Johnson; D N Taylor; R A Finkelstein; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge.

Authors:  D K Sengupta; M Boesman-Finkelstein; R A Finkelstein
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  Structural characterization of the extracellular polysaccharide from Vibrio cholerae O1 El-Tor.

Authors:  Fitnat Yildiz; Jiunn Fong; Irina Sadovskaya; Thierry Grard; Evgeny Vinogradov
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

8.  Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.

Authors:  Mohammad Kamruzzaman; Meagan Kelly; Pavol Kováč; Peng Xu; Edward T Ryan; Richelle C Charles; Jason B Harris; Stephen B Calderwood; Aklima Akter; Rajib Biswas; M Hasanul Kaisar; Taufiqur R Bhuiyan; Louise C Ivers; Ralph Ternier; Jean-Gregory Jerome; Hélene B Pfister; Xiaowei Lu; Sameh E Soliman; Bart Ruttens; Rina Saksena; Jana Mečárová; Alžbeta Čížová; Firdausi Qadri; Slavomír Bystrický
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.